BiotechCR
Biotech de Costa Rica donde CONIS tarda 24 meses para aprobar ensayos, la CCSS solo compra a farmacéuticas internacionales aprobadas y Medtronic/Boston Scientific usan caminos regulatorios de EE.UU.
Declive de años antes del cierre final · Error fatal: Costa Rica biotech: CONIS (CCSS bioethics committee) clinical trial approval process took 18-24 months. CCSS (national health insurance, 95% of population) had procurement for approved international pharmaceutical suppliers only. Ministerio de Salud device registration required 24+ months. Costa Rica's medical device exports (Medtronic, Boston Scientific factories) used US parent regulatory pathways. Local biotech had no commercial pathway.
| Fundada | 2018 |
|---|---|
| Cerrada | 2023 |
| País | Costa Rica |
| Sector | Biotech |